Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Our approach includes a targeted mix of hormonal treatments, carefully chosen nutraceuticals, and personalized nutritional guidance derived from individual lab tests. We aim to reactivate genes that have become inactive as a result of aging. Our studies indicate that this method can not only stabilize but potentially enhance vision in nearly half of the participants suffering from macular degeneration. Additionally, it could decrease the frequency of eye injections and reduce the chances of the condition worsening from the dry type to the more severe wet type.
We highly advocate for patients to undertake this program, which is grounded in scientific research, as soon as possible. Early participation can significantly diminish the likelihood of the disease advancing to an irreversible stage.
Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Difficulty seeing in dim light.
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory.
Difficulty seeing in dim light..
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory
The HOMING Method guides the personalized care plan for Age-related Macular Degeneration (AMD).
HOMING is an acronym for Hormones, Oxidation, Methylation, Inflammation, Nutrition and Genetics. The goal is to improve cell biochemistry either directly or by epigenetic mechanisms, (reawakening dormant genes that down regulate with aging)
Literature Citation demonstrating stability and improvement of dry and wet AMD
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
48% of dry AMD improved.
60% of wet AMD improved.
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
The HOMING method has been a success in many clinical conditions indicating that addresses root causes of disease.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Board Certified Ophthalmology
Ph.D. in Biochemistry
Board Certified Ophthalmologist / Biomedical Engineer
PhD in Biochemistry
Imagine waking up one day to find the world around you slowly getting blurrier, the vibrant colors and sharp edges you once took for granted now a distant memory. This is the reality for millions of people suffering from macular degeneration, a condition that, until recently, offered little hope for reversal. However, Anne Marie's story paints a different picture, one filled with hope, transformation, and the power of dedicated medical research and personalized care.
Anne Marie embarked on the Macular Program with a mix of hope and skepticism. For years, she struggled with the debilitating effects of macular degeneration, including severe blurry vision that clouded her daily life. But within just the first 24 hours of starting the program, her longstanding issue with blurry vision vanished. "It was like a veil had been lifted," she recalls. The rapid improvement in her vision was just the beginning.
As days passed, Anne Marie observed more changes, extending beyond her eyesight. She noted improvements in her leg varicosity, with significant pain and cramping in her upper left thigh subsiding to a minor, occasional annoyance. Her body temperature normalized, her energy levels surged, and even the massive hair shedding she had battled for years dramatically reduced. "Showering and washing my hair no longer consumed all my energy for the day," she shares, highlighting the profound impact on her overall well-being.
These remarkable improvements stem from the innovative approach of the Macular Program, spearheaded by medical experts Dr. George W. Rozakis and Dr. Brian Bakke. Their pioneering work focuses on personalized care plans involving nutrition, nutraceuticals, and hormones, tailored to optimize cellular biochemistry based on individual history and blood testing. This holistic approach not only aims to improve vision but also addresses overall health, striving to halt or even reverse cell degeneration.
Anne Marie's story is a testament to the potential of this program. From near despair to renewed hope, her journey is a beacon for others facing similar challenges. It underscores the importance of innovative, personalized medical interventions in tackling complex health issues.
The Macular Program's success, as seen through Anne Marie's experience, offers a compelling call to action for individuals grappling with macular degeneration. It's a reminder that with the right approach, the journey towards healing and recovery is possible. Anne Marie's story is not just about the restoration of her vision; it's about reclaiming her life, one day at a time.
This narrative is more than just a testimonial; it's a beacon of hope for many. If you or a loved one are facing the challenges of macular degeneration, take heart from Anne Marie's journey. Explore the possibilities that the Macular Program offers and consider taking that first step towards a brighter, clearer future. The road to recovery starts with believing that change is possible, and Anne Marie's story is proof that with the right support, even the most daunting challenges can be overcome.
Our study followed patients for 6 months. Those who improved did so generally between 2 and 6 months. Unpublished data is showing that these effects are not lost out to 2-3 years and additional improvement is possible with more time. Time and compliance with the program are the keys to continued success.
Similar to exercise and dietary practices, the favorable changes in your blood chemistry can only be sustained as long as you are taking your program.
Yes. Consistently adhering to our program has led to marked improvements for our patients. It is the combination of time and unwavering commitment to the program that paves the way for enduring success.
This decision is made by you retina doctor. However it is reasonable to ask to decrease the time between injection if the OCT scans show no remaining fluid because the HOMING Method, according to scientific literature, may decrease the creation of growth factors in the eye (for which you are receiving the injections).
The Macular Program is a form of anti-aging medicine since macular degeneration is actually called AGE RELATED macular degeneration. Fighting aging is fighting AMD. What is nice is that treating AMD with HOMING also benefits other aging symptoms which is why we want to know about your eye AND General Health.
Age-Related Macular Degeneration (AMD), whether dry or wet, is a complex condition influenced by numerous factors. Our HOMING method helps to prevent, stabilize and even reverse macular degeneration.
Geographic Atrophy is a special form of dry macular degeneration that is felt to be caused by inflammation. The HOMING method reduces inflammation. Our clinical suspicion is that GA does not worsen if a patient is on the HOMING Method. This is an important matter because new drugs now exist to fight inflammation in eyes with GA, but these drugs need to be injected into the eye. We hope the HOMING method will allow patients to avoid eye injections for GA. The smart move is to be on the HOMING method and have the GA closely followed for progression. If no progression, then you don’t need shots. It’s your call.
MacularProgram© 2023 | All Rights Reserved